Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many complications were reported by women who underwent a medical abortion after ingesting (a) mifepristone as the first step of a medical abortion and (b) misoprostol as the second step of a medical abortion in (i) 2017, (ii) 2018 and (iii) 2019.

The number of medical abortions for 2017 and 2018 with complications recorded on the abortion notification form where antiprogesterone and prostaglandin were recorded as prescribed is in the attached table. Mifepristone is a type of antiprogesterone and misoprostal is a type of prostaglandin.

The Code of Practice outlined in the Statistics and Registration Service Act 2007 prohibits the pre-release of official statistics before the due date of publication. Data on complications in 2019 is still being collected and requires full quality assurance prior to release. Data for 2019 is due to be published on 11 June.